Intercept Pharmaceuticals Inc.

NAS: ICPT

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Intercept Pharmaceuticals Inc.

Market open

ICPT
/zigman2/quotes/202434567/composite

$

19.62

Change

+0.60 +3.15%

Volume

Volume 91,177

Feb 6, 2023, 11:00 a.m.

Real time quotes

/zigman2/quotes/202434567/composite

Previous close

$ 19.02

$ 19.62

Change

+0.60 +3.15%

Day low

Day high

$18.90

$19.68

Open
Open: 19.03

52 week low

52 week high

$10.81

$21.25

Open

Market cap

$787.75M

Average volume

756,698

P/E ratio

3.40

Rev. per Employee

$755,906

EPS

5.74

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/icpt

MarketWatch News on ICPT

  2. Two Years Later, Intercept Takes Another Run at NASH

    10:13 a.m. July 8, 2022

    - Barron's Online

  3. Intercept set to meet with FDA in July about NASH drug

    7:30 a.m. June 6, 2022

    - Jaimy Lee

  5. Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

    8:22 a.m. Aug. 3, 2021

    - Tomi Kilgore

  6. The FDA's Biogen Decision Will Cause Waves Across Biotech

    8:20 p.m. June 1, 2021

    - Barron's Online

  7. Intercept Pharmaceuticals downgraded to neutral from buy at B. Riley

    6:23 a.m. May 26, 2021

    - Tomi Kilgore

  9. Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR

    7:28 a.m. Nov. 20, 2020

    - Tomi Kilgore

  10. Intercept Pharmaceuticals upgraded to outperform from market perform at Raymond James

    7:47 a.m. Nov. 10, 2020

    - Tomi Kilgore

  12. Intercept shares gain after it announces layoffs

    7:19 a.m. Sept. 2, 2020

    - Jaimy Lee

  13. A Top Contender Drops Out of Race for a NASH Drug

    10:15 a.m. July 23, 2020

    - Barron's Online

  14. Biogen Submits Troubled Alzheimer’s Drug for FDA Approval

    11:07 a.m. July 8, 2020

    - Barron's Online

  15. Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.

    10:53 a.m. June 30, 2020

    - Barron's Online

  16. Intercept Pharmaceuticals downgraded to market perform at BMO Capital

    8:07 a.m. June 30, 2020

    - Tomi Kilgore

  17. Intercept Pharmaceuticals stock price target cut to $97 from $158 at B. Riley FBR

    6:53 a.m. June 30, 2020

    - Tomi Kilgore

  18. Intercept Pharmaceuticals stock price target cut to $50 from $89 at SVB Leerink

    5:11 a.m. June 30, 2020

    - Tomi Kilgore

  19. Intercept Shares Tumble on NASH Disappointment

    3:05 p.m. June 29, 2020

    - Barron's Online

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/icpt

Other News on ICPT

  2. Intercept updates Phase 3 data for the NASH candidate

    9:26 a.m. Nov. 7, 2022

    - Seeking Alpha

  3. Intercept updates Phase 3 data for the NASH candidate

    9:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  4. Intercept updates Phase 3 data for the NASH candidate

    9:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  5. Intercept updates Phase 3 data for the NASH candidate

    9:22 a.m. Nov. 7, 2022

    - Seeking Alpha

  7. Intercept Pharmaceuticals: Trying Times

    11:30 p.m. Nov. 3, 2022

    - Seeking Alpha

  9. 10-Q: INTERCEPT PHARMACEUTICALS, INC.

    3:05 p.m. Nov. 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. MNSO and CLEU among mid-day movers

    12:40 p.m. Nov. 1, 2022

    - Seeking Alpha

  15. Notable earnings before Tuesday's open

    10:21 a.m. Oct. 31, 2022

    - Seeking Alpha

  17. Akero: Putting Together The Pieces They Let Us See

    5:51 p.m. Oct. 25, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/icpt

Press Releases on ICPT

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.